Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Meropenem × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Febrile Neutropenia 2 Urinary Bladder Neoplasms 1 Sepsis 1 Neoplasms 1 Fever 1 Emergencies 1

Interventions

Exercise 15 Drug Therapy 15 Capecitabine 10 Blood Specimen Collection 10 Surveys and Questionnaires 9 Radiotherapy 9 pembrolizumab 8 Paclitaxel 8 Dexamethasone 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 6 Interviews as Topic 6 Fluorouracil 6 Biopsy 6 apatinib 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Cyclophosphamide 5 Cisplatin 5 atezolizumab 4 Therapeutics 4 Radiosurgery 4 Positron Emission Tomography Computed Tomography 4 Nutritional Status 4 Methylprednisolone 4 Ipilimumab 4 Injections 4 Gemcitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05393505 2022-12-06

FRANCiS-NF

The University of Hong Kong

Phase 4 Unknown

Classical hematology

Emergencies, Neoplasms, Sepsis, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡